Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Respiratory
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
RSV Infection Burden High in Immunocompromised Adults
July 2026
RSV infection poses a substantial severe disease burden for immunocompromised adults in high-income countries.
Read more
19 May 2026
ATS 2026: Itepekimab COPD Trial Shows Mixed Results
Itepekimab reduced COPD exacerbations in one Phase III trial, but the effect was not replicated across AERIFY-2.
19 May 2026
Heat Vulnerability Outpaces ICU Capacity in U.S.
Extreme heat is exposing state-level ICU capacity gaps in regions already facing high climate-related health risk.
18 May 2026
ATS 2026: Phase IIIb Trial Advances MAC Lung Disease Care
A Phase IIIb trial is evaluating inhaled amikacin for newly diagnosed Mycobacterium avium complex lung disease.
17 May 2026
ATS 2026: TETON-1 Inhaled Treprostinil Slows IPF Decline
Inhaled treprostinil slowed lung function decline in TETON-1, a Phase III trial in idiopathic pulmonary fibrosis.
16 May 2026
Gabapentinoids Linked to Higher Asthma Risk
Gabapentinoids may increase asthma exacerbation risk in adults treated for chronic or neuropathic pain.
14 May 2026
Age Alone Should Not Rule Out Lung Cancer Surgery
Lung cancer surgery showed durable survival and quality-of-life outcomes in carefully selected octogenarians with early-stage NSCLC.
12 May 2026
New Bird Flu Risks Found on California Dairy Farms
H5N1 influenza surveillance on California dairy farms found airborne virus, wastewater contamination, and subclinical infections in cows.
9 May 2026
Hot Nights Increase Emergency Department Visits in Asthma
Extreme heat was linked to higher asthma emergency department visits among adults and children in Baltimore, especially after hot nights.
Loading posts...
« Previous
1
2
3
4
5
…
37
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View